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Dyspnea is an impairing symptom in obstructive pulmonary diseases. Besides multiple
physiological pathways contributing to this sensation recent research has demonstrated an
important role of psychological factors in the perception of dyspnea. The present review
article synthesizes the research literature with regard to psychological aspects of the
perception of dyspnea as well as other dyspnea-related issues such as course of disease,
neuropsychological correlates and interventions that focus on psychological or behavioural
changes. The available data show that inaccurate perception of dyspnea is related to
poorer treatment outcome in obstructive pulmonary diseases and is impacted upon by
emotional, attentional and learning processes. Neuropsychological deficits might further
contribute to this association. Different psychological and behavioural interventions might
reduce comorbid psychological disorders and thus improve the perception of dyspnea.
However, future research is clearly required to substantiate current findings.
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Dyspnea, or breathlessness, is defined as the subjective
experience of breathing discomfort, which comprises
qualitatively distinct sensations whose intensity can vary.
These sensations originate from interactions among multiple
physiological, social, psychological and environmental fac-
tors.1 Breathlessness is an unpleasant and frightening
symptom in asthma, chronic obstructive pulmonary disease
(COPD) and a variety of other cardiopulmonary and
neuromuscular diseases, causing considerable limitations
to functional status and quality of life as well as a
considerable socio-economic burden.
Over the past years research on dyspnea has predomi-
nantly focused on peripheral mechanisms contributing to this
sensation.1–3 However, research into potential psychological
and neuropsychological factors contributing to the percep-
tion of breathlessness has long been neglected, although
these factors considerably influence this interoceptive
process. In the following, we review the available evidence
on how different psychological aspects are related to the
perception of dyspnea in obstructive pulmonary diseases, the
course of disease and its treatment. Studies were selected
from literature searches in relevant databases (PubMed,
Embase) using the terms dyspnea or breathlessness and
perception, asthma, COPD, psychology, neural, cortical,
mood, emotion, attention, learning, intervention and ther-
apy as well as their combinations. Additional studies were
identified by searching bibliographies of retrieved studies.
We limited the search to English-language articles published
from 1 January 1980 to 30 September 2005 (see Tables 1–5).
Perception of dyspnea and course of disease
Asthma
Current guidelines concerning the treatment of asthma
emphasise the active and self-responsible role of patients in
the further course of disease, after having been diagnosed
and stabilised with appropriate medication by their physi-
cian.4 The adequate perception of onset and severity of
developing bronchoconstriction and associated dyspnea is
the sine qua non of these self-management programs. It
forms the basis of all further self-imposed measures such as
regular self-medication, reduction of physical exercise,
allergen avoidance or visits to the physician and emergency
department. In contrast, over-perception of asthmatic
breathlessness might be associated with over-medicationand the related medical side effects, while under-percep-
tion entails the potential risk of delayed treatment.5
Inadequate symptom perception in patients with asthma
has, indeed, been reported in a variety of studies using
different methods.6–15 The main finding was a discrepancy
between objectively measured lung function and subjec-
tively reported symptoms for both over and under-percep-
tion of dyspnea which, in turn, leads to poor treatment
outcome. In this regard, Dirks et al.16 reported that 26% of
the examined patients with asthma could not adequately
estimate their symptoms. This subgroup showed an in-
creased rate of rehospitalisation of 40% in the following six
months when compared to the patients who displayed
correct symptom perception. A field study by Main and
colleagues17 showed that incorrect perception of the
severity of asthma (i.e., associating non-specific symptoms
with asthma) led to a significant overuse of reliever
medication, irrespective of lung function. Notably, this
association was mediated by negative mood.
Particularly in the case of life threatening and fatal asthma
attacks a blunted perception of dyspnea has been assumed to
be a causal factor.10–15 Kikuchi et al.10 experimentally induced
dyspnea in patients who had or had not previously experi-
enced near fatal asthma attacks and in healthy volunteers.
Patients with a history of near fatal attacks perceived
significantly less dyspnea than patients without such a history
and healthy controls. Similarly, in a study by Magadle et al.,15
26% of 113 patients with asthma showed blunted symptom
perception. During the following 2 years this group, when
compared to those patients with accurate symptom percep-
tion, exhibited a fourfold rate of visits to the emergency
department, a more than five-fold hospitalisation rate and a
six-fold rate of near fatal and fatal asthma attacks.
COPD
Bronchodilating medication is also recommended to control
symptoms of dyspnea in COPD,18 and is often self-adminis-
tered on a self-perceived needs basis. Therefore, adequate
symptom perception is crucial to a successful self-manage-
ment in COPD. Deficits in the symptom perception, however,
also occur in COPD patients, as demonstrated by Hoyer
et al.19 In their study patients with either COPD or asthma as
well as healthy controls rated their current level of
bronchoconstriction followed by a spirometric lung function
test. Compared to the healthy control group, patients
with COPD showed an under-estimation of their lung
function, while those with asthma over-estimated their lung
function. Gottfried et al.20 showed that patients with COPD
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Table 1 Studies examining the perception of dyspnea and course of disease.
Authors Study design Participants (gender, age) Intervention Main outcome measures
Dirks et al.16 Prospective
observational
study
587 asthmatics (f: 396,
age: 14–84 yrs)
Symptom checklists,
follow-up-
questionnaires
Mislabelling of symptoms,
personality
characteristics, number
of rehospitalisations
Main et al.17 Prospective
observational
study
42 asthmatics (f: 28,
mean age: 46 yrs)
Field study with daily
recordings on 7
consecutive days
Asthmatic symptoms,
non-specific symptoms,
mood, reliever
medication use, PEF
Kikuchi et al.10 Prospective quasi-
experimental
study
11 asthmatics with near
fatal attacks (f: 7, mean
age: 39 yrs), 11
asthmatics without near
fatal attacks (f: 4, mean
age: 32 yrs), 16 controls
(f: 3, mean age: 33 yrs)
Resistive load
breathing
Borg score of dyspnea
Magadle et al.15 Prospective
observational
study
113 asthmatics (f: 59,
mean age: 38 yrs)
Resistive load
breathing; follow-up
for 2 years
Borg score of dyspnea,
ED-visits, hospitalisation
rate, near-fatal and fatal
attacks, reliever
medication use, PEF
Hoyer et al.19 Prospective quasi-
experimental
study
30 asthmatics (f: 12,
mean age: 47 yrs), 30
COPD patients (f: 10,
mean age: 51 yrs), 31
controls (f: 11, mean age:
52 yrs)
Estimation of PEF/
FEV1 prior to
spirometric lung
function test,
symptom checklist
VAS scores of estimated
lung function, symptom
scores
Gottfried et al.20 Prospective quasi-
experimental
study
14 COPD patients (mean
age: 59 yrs), 12 controls
(mean age: 65 yrs)
Resistive and elastic
load breathing,
breathing manoeuvres
Exponents and intercepts
of magnitude estimation
ED ¼ emergency department, f ¼ female, FEV1 ¼ forced expiratory volume in 1 s, PEF ¼ peak expiratory flow, VAS ¼ visual analog
scale.
Perception of dyspnea 413under-estimated resistive and elastic loads compared to
healthy controls with comparable ventilatory parameters
during a magnitude scaling test. Since increasing dyspnea,
even at low levels of physical activity, is a typical feature of
COPD, a progressive avoidance of activities is very common
among patients. This can result in a vicious circle where a
considerable physical deconditioning leads to more dyspnea
under lower activity levels, which in turn results in
associated negative consequences for the general well being
and quality of life. Inadequate perception of dyspnea
contributes to this vicious circle and results in poor self-
management of COPD.Neuropsychological processing of dyspnea
Recent work has suggested a variety of potential physiolo-
gical mechanisms to contribute to a blunted perception of
breathlessness including bronchial inflammation, disease
severity, reduced chemosensitivity, age, gender, reduced
muscle force and adaptation processes.1,2 Little is known,
however, about the cortical and neuropsychological pro-
cesses underlying the perception of dyspnea. Animal studies
suggested a role of corollary discharges.3 These are efferent
copies of outgoing motor signals to the respiratory muscles,which are sent to sensory brain areas. Expanding on this, the
theory of afferent mismatch assumes that a dissociation
between efferent signals to the respiratory muscles and
afferent receptor feedback of the muscles’ efficiency is
involved in the perception of dyspnea.1,3 Until present, only
a few imaging studies in this field have been published,
mostly examining healthy individuals. The main finding is
that activation in the anterior insula and anterior cingulate
cortex appears to be important to the perception of
breathlessness.21 These are areas that are found active in
virtually all imaging studies of pain. Therefore, a common
cortical network underlying the perception of both sensa-
tions has been assumed.22 Despite these first findings, the
complex interactions and interrelations between the
assumed components are far from being understood.
There are also first indications of specific deficits in the
neuropsychological processing of dyspnea in patient groups.
Davenport et al.23 reported an absence of early respiratory
related evoked potentials (RREP) in the electroencephalo-
gram (EEG) after short respiratory occlusions in a subgroup
of children who had experienced near fatal asthma attacks.
Thus, the dyspneic sensory signal does not appear to have
activated the somatosensory cortex, which is usually
found active in healthy individuals. Similarly, Webster and
Colrain24 demonstrated reduced later RREPs following
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Table 2 Studies examining the neuropsychological processing of dyspnea.
Authors Study design Participants (gender, age) Intervention Main outcome measures
Davenport et al.23 Prospective quasi-
experimental
study
11 asthmatic children with
near fatal attacks (f: 3,
mean age: 11 yrs), 15
asthmatic children without
near fatal attacks (f: 4,
mean age: 15 yrs), 14
matched healthy controls
Electroencephalogram
during inspiratory
occlusion
Respiratory related
evoked potentials (RREP)
Webster and
Colrain24
Prospective quasi-
experimental
study
16 asthmatics (f: 8, mean
age: 22 yrs), 16 controls
(f: 8, mean age: 21 yrs)
Electroencephalogram
during inspiratory
occlusion and auditory
stimulation
Respiratory related
evoked potentials
(RREP), auditory evoked
potentials (AEP)
Harper et al.25 Prospective quasi-
experimental
study
14 children with CCHS (f: 7,
mean age: 11 yrs), 14 healthy
controls (f: 6, mean age:
11 yrs)
Functional magnetic
resonance imaging during
breathing of CO2 (5%)
De-/activations of brain
areas (BOLD signals)
Macey et al.15 Prospective quasi-
experimental
study
13 children with CCHS (f: 6,
mean age: 11 yrs), 14 healthy
controls (f: 7, mean age:
11 yrs)
Functional magnetic
resonance imaging during
cold pressor challenge
De-/activations of brain
areas (BOLD signals)
Harver et al.50 Prospective quasi-
experimental
study
6 young healthy adults (f: 3,
mean age: 27 yrs), 6 old
healthy adults (f: 3, mean
age: 62 yrs)
Electroencephalogram
during in-/exspiratory
occlusion during
attention vs. distraction
Respiratory related
evoked potentials (RREP)
f ¼ female, CCHS ¼ congenital central hypoventilation syndrome.
Table 3 Studies examining the affective and sensory aspects of dyspnea.
Authors Study design Participants (gender, age) Intervention Main outcome measures
Wilson and
Jones28
Prospective
experimental
study (RCT)
10 healthy adults (f: 6,
age: 22-34 yrs)
Incremental cycle-
ergometer exercise
Borg scores of intensity
and distress of dyspnea,
ventilatory measures
Meek et al.29 Prospective
observational
study
27 asthmatics (f: 10,
mean age: 60 yrs), 32
COPD patients (f: 11,
mean age: 64 yrs), 33
controls (f: 21, mean age:
63 yrs)
Field study with daily
recordings on 14 or 28
consecutive days
VAS scores for breathing
effort and breathing
distress, symptoms, mood
Lehrer et al.30 Retrospective
observational
study plus
prospective
experimental
study (RCT)
46 asthmatics (age: 18-
40 yrs)
Retrospective
quantification of
descriptors of
symptoms,
ipratropium bromide
versus placebo
Line drawings and
numerical quantification
of verbal descriptors of
asthma symptoms,
spirometric variables
Carrieri-Kohlman
et al.31
Prospective quasi-
experimental
study
52 COPD patients (f: 27,
mean age: 67 yrs)
6-min walk test,
incremental treadmill
exercise
VAS scores for distress,
anxiety, effort and
intensity of dyspnea,
ventilatory measures
von Leupoldt and
Dahme32
Prospective quasi-
experimental
study
10 healthy adults (f: 7,
mean age: 35 yrs)
Resistive load
breathing
VAS scores of
unpleasantness and
intensity of dyspnea,
ventilatory measures
f ¼ female, RCT ¼ randomized controlled trial, VAS ¼ visual analog scale.
A. von Leupoldt, B. Dahme414
ARTICLE IN PRESS
Table 4 Studies examining the influence of emotions, learning and attention on the perception of dyspnea.
Authors Study design Participants (gender,
age)
Intervention Main outcome measures
Put et al.33 Prospective quasi-
experimental
study
32 asthmatics (f: 16,
mean age: 40 yrs)
Inhalation from placebo
inhalers with suggestion of
bronchoconstrictive or
dilative effect
Symptom checklist,
measures of affectivity,
ventilatory measures
Bogaerts et al.34 Prospective quasi-
experimental
study
48 healthy adults
(f: 48, age: 18-32 yrs)
Inhalation of CO2 (7.5 and
10%) in pleasant or
unpleasant context
Symptom checklist,
measures of affectivity,
ventilatory measures
Affleck et al.35 Prospective
observational
study
48 asthmatics (f: 31,
mean age: 42 yrs)
Field study with daily
recordings on 21
consecutive days
Asthma symptoms, mood,
PEF, bronchodilator use
Rietveld and Prins36 Prospective
experimental
study (RCT)
40 asthmatic children
(mean age: 12 yrs)
Physical exercise,
negative emotion
induction by viewing a film
Dyspnea ratings, FEV1,
measures of affectivity
van den Bergh et al.41 Prospective quasi-
experimental
study
28 psychosomatic
patients (f: 14, mean
age: 36 yrs)
Conditioning of pleasant
and unpleasant odors with
inhalation of CO2 (7.4%)
Symptom checklist,
measures of affectivity,
ventilatory measures
De Peuter et al.42 Prospective quasi-
experimental
study
20 asthmatics (f: 10,
mean age: 24 yrs), 20
controls (f: 9, mean
age: 24 yrs)
Conditioning of
specifically labelled
aerosols with inhalation of
CO2 (5%) or O2 (100%)
Symptom checklist,
measures of affectivity,
ventilatory measures
Thornby et al.46 Prospective
experimental
study (RCT)
36 COPD patients
(f: 25, mean age:
63 yrs)
Treadmill exercise while
listening to music, grey
noise, silence
Borg score, exercise time,
external work
Bauldoff et al.47 Prospective
experimental
study (RCT)
24 COPD patients
(f: 20, mean age:
68 yrs)
Home-based treadmill or
walking exercise on 2–5
days/week for 8 weeks
with vs. without listening
to music
Borg score during
activities of daily living
and 6-min walk test, 6-min
walking distance,
measures of affectivity
and health-related quality
of life
Pfister et al.48 Prospective
experimental
study (RCT)
19 COPD patients (f: 8,
mean age: 72 yrs)
6min treadmill exercise
with vs. without listening
to music
Borg score, walking
distance
Brooks et al.49 Prospective quasi-
experimental
study
30 COPD patients
(f: 15, mean age:
70 yrs)
10min walking exercise
with vs. without listening
to music
Borg score, walking
distance, anxiety score
Feldman et al.72 Retrospective
observational
study
27 asthmatics (f: 16,
mean age: 38 yrs) 21
asthmatics with
comorbid panic
disorder (f: 16, mean
age: 41 yrs)
Retrospective chart
review of previous 12
months, questionnaires,
spirometry
Physician visits, use of
emergency medication,
hospitalisations, asthma
symptoms, FEV1, asthma
related quality of life
f ¼ female, FEV1 ¼ forced expiratory volume in 1 s, PEF ¼ peak expiratory flow, RCT ¼ randomized controlled trial, VAS ¼ visual
analog scale.
Perception of dyspnea 415respiratory occlusion in asthmatic adults compared to
healthy controls. Most interestingly, these reductions in
the P3 amplitude were also found in the patient group after
a short auditory stimulus. Hence, the authors discussed a
possible general deficit in the neuropsychological processing
of perceptual information in specific patient groups. These
findings are partly confirmed by imaging studies in children
with congenital central hypoventilation syndrome (CCHS), a
disorder which affects the autonomic control of breathing.
Harper et al.25 found reduced or even diametrically opposedbrain activations in children with CCHS compared to a
healthy control group during inspiration of increased CO2
levels. These distinctive patterns of activation were also
partly observed in the same brain areas (e.g., the insula)
during stimulation with painful cold.26 This is in line with the
findings of Davenport et al.23 and Webster und Colrain,24
suggesting a possible role of neural deficits in blunted
perception of dyspnea. Further studies are clearly required,
however, to extend our knowledge on the involvement of
these neuropsychological factors.
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Table 5 Studies examining psychological and behavioural interventions in the treatment of dyspnea.
Authors Study design Participants (gender,
age)
Intervention Main outcome measures
Vogt and
Schandry9
Prospective
observational
study
53 asthmatics (f: 40,
mean age: 53 yrs)
Field study with twice
daily recordings plus
visual feedback on 30
consecutive days
Symptom checklist,
estimated PEF, measured
PEF
Leopold and
Schandry56
Prospective
observational
study
EG: 29 asthmatics CG:
26 asthmatics (total
sample f: 34, mean
age: 52 yrs)
2-month computer-
assisted field study with
twice daily recordings
plus visual feedback vs.
standard self-assessment
without feedback and
symptom ratings
Symptom checklist,
estimated PEF, measured
PEF, medication use,
asthma-related quality of
life
Harver58 2 prospective
experimental
studies (RCTs)
(a) EG: 7 asthmatics
(f: 3, mean age:
19 yrs), CG: 6
asthmatics (f: 3,
mean age: 20 yrs)
(b) EG: 8 asthmatics
(f: 4, mean age:
20 yrs) plus 8
healthy adults
(f: 3, mean age:
19 yrs)CG: 6
asthmatics (f: 5,
mean age: 19 yrs)
plus 6 healthy
adults (f: 4, mean
age: 19 yrs)
Signal detection of
resistive loads with vs.
without feedback in 3
experimental sessions in
both studies
Sensitivity to added
loads, correct responses,
response bias
McLacklan et al.59 Prospective
experimental
study (RCT)
(a) EG: 12 asthmatic
children CG: 10
asthmatic children
(total sample: age:
9-12 yrs)
Signal detection of
resistive loads with vs.
without feedback in 3
experimental sessions
Sensitivity to added
loads, correct responses,
response bias
Dahme et al.60 Prospective quasi-
experimental
study
EG: 15 asthmatics
(f: 8, mean age:
46 yrs), CG: 15
asthmatics
(f: 8, mean age:
43 yrs)
Biofeedback training to
lower respiratory
resistance on 3 days/
week for 4 weeks
Sensitivity to added
loads, VAS scores of
dyspnea
Nguyen et al.61 Prospective
observational
study
16 COPD patients
(f: 8, mean age:
69 yrs)
3-month Internet-based
dyspnea self-
management program
Dyspnea scores, self-
efficacy, perception of
control/social support/
general health, exercise
behaviour
Weiner et al.64 Prospective quasi-
experimental
study
22 asthmatics (f: 8,
mean age: 34 yrs),
Incremental inspiratory
muscle training on 6
days/week for 3 months
vs. sham training,
resistive load breathing
Borg score, medication
use, inspiratory muscle
strength
Weiner et al.65 Prospective quasi-
experimental
study
EG: 19 COPD patients
(f: 4, mean age:
66 yrs)CG: 19 COPD
patients (f: 3, mean
age: 65 yrs)
Incremental inspiratory
muscle training on 6
days/week for 3 months
followed by 3 days/week
with incremental training
in EG vs. mild training in
CG for 12 months, 6-min
Borg score, inspiratory
muscle strength and
endurance, Borg score
during activities of daily
living, 6-min walking
distance
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Table 5 (continued )
Authors Study design Participants (gender,
age)
Intervention Main outcome measures
walk test, resistive load
breathing
Kunik et al.69 Prospective
experimental
study (RCT)
EG: 21 COPD patients
CG: 27 COPD patients
(total sample mean
age: 71 yrs)
2 h of cognitive
behavioural group
therapy with home
practice and weekly calls
in the subsequent 6 weeks
vs. 2 h of patient
education followed by
weekly calls in the
subsequent 6 weeks
Health-related quality of
life, scores for anxiety
and depression, 6-min
walking distance, FEV1
Ross et al.70 Prospective
experimental
study (RCT)
EG: 15 asthmatics
with comorbid panic
disorder (f: 15, mean
age: 38 yrs) CG: 10
asthmatics with
comorbid panic
disorder (f: 10, mean
age: 41 yrs)
8 weeks of cognitive
behavioural group
therapy plus asthma
education vs. waitlist
control
Panic, anxiety and
depression scores,
asthma symptoms, PEF,
asthma-related quality of
life
Renfroe71 Prospective
experimental
study (RCT)
EG: 12 COPD patients
CG: 8 COPD patients
(total sample: f: 10,
mean age: 61 yrs)
4 weekly group sessions
(45min) of instructed
progressive relaxation
plus home practice vs. 4
weekly sessions without
relaxation instructions
VAS score of dyspnea,
anxiety score, ventilatory
measures
Put et al.51 Prospective
experimental
study (RCT)
EG: 12 asthmatics
(f: 5, mean age:
43 yrs) CG: 11
asthmatics
(f: 7, mean age:
48 yrs)
6 1 h individual sessions of
psycho education,
behavioural and cognitive
techniques plus home
practice vs. waitlist
control
Affectivity scores, asthma
symptoms, PEF, asthma
related quality of life,
knowledge attitude, self-
efficacy, adherence scale
CG ¼ control group, EG ¼ experimental group, f ¼ female, FEV1 ¼ forced expiratory volume in 1 s, PEF ¼ peak expiratory flow,
RCT ¼ randomized controlled trial, VAS ¼ visual analog scale.
Perception of dyspnea 417Psychological factors and the perception of
dyspnea
Affective and sensory aspects of dyspnea
Previous papers have pointed out a number of similarities
between the perception of dyspnea and pain. Therefore, the
adaptation of successful paradigms and instruments from
the far more advanced area of pain research has been
suggested to research on breathlessness.21,22,27 Particularly
the realization of the multidimensionality of pain, i.e., a
differentiation between sensory and affective aspects of the
sensation, has lead to the development of important pain
measurement instruments, research paradigms and disease
models. A similar differentiation between the sensory and
affective dimensions of breathlessness has thus far received
limited attention, although first evidence for such a
distinction is available.28–32 In this regard, Meek et al.29
and Carrieri-Kohlman et al.31 demonstrated differences
between perceived intensity and distress in patients with
COPD in the everyday life and during walking or treadmillexercise, respectively. Similar differences between sensory
intensity and affective unpleasantness were observed in
healthy volunteers while breathing through inspiratory
resistive loads32 or during cycle-ergometer exercise.28 Since
the affective dimension of perceived dyspnea might be
specifically vulnerable to emotional influences and might
also be a particularly motivating factor in seeking adequate
treatment,5 the investigation of this dimension appears
important to future research.
Emotions and dyspnea
Emotions play an important role in the perception of
breathlessness. Studies so far have predominantly demon-
strated that negative affectivity is associated with de-
creased accuracy in the perception of dyspnea which might
contribute to poor treatment outcome as explicated above.
Following this lead, Put et al.33 demonstrated that after
inhaling a placebo substance, which was believed to
be a bronchoconstrictive agent, patients with asthma who
showed high negative emotionality perceived more dyspneic
ARTICLE IN PRESS
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ality. These patients further reported a higher level of
asthma-related complaints in general than did those with
low negative emotionality. Similarly, Bogaerts et al.34
showed that individuals with high negative affectivity,
compared to those with low negative affectivity, are
less accurate in the perception of induced dyspnea, in
particular in a distressing experimental context. One of
the few field studies in this area35 confirmed these findings
in 48 patients with asthma by showing that during episodes
of negative mood more symptoms of breathlessness were
reported.
An influence of emotions on the perception of dyspnea has
also been obtained in paediatric patients. Children with
asthma, in a study by Rietveld and Prins,36 reported more
symptoms of breathlessness after a physical exercise test if
they had watched a negative mood-inducing movie clip
beforehand. Control groups without negative mood induc-
tion prior to testing perceived fewer symptoms, although
lung function was comparable. However, the influence of
positive emotionality has been rarely examined in previous
studies. In light of high comorbidity rates of affective and
anxiety disorders in obstructive pulmonary diseases,37–40
future research into emotional influences on the perception
of dyspnea is clearly indispensable.
Learning processes and dyspnea
Learning processes are known to have an impact on the
perception of breathlessness similar to that which they have
on the perception of pain. In this regard, van den Bergh
et al.41 demonstrated that patients with psychosomatic
symptoms can acquire symptoms of breathlessness by
classical conditioning, i.e. odors were coupled with CO2
inhalation. In the following presentation of the conditioned
stimulus increased symptom reports were shown specifically
for an unpleasant odor. The same group replicated these
learning effects by coupling CO2 with specifically labelled
aerosols in participants with asthma and also in healthy
participants.42 In particular a subgroup of participants with
asthma who exhibited symptoms of hyperventilation showed
a pronounced learning effect with increased dyspnea ratings
after using the conditioned aerosol, which was completely
free of CO2.
In his model of dyspnea, Rietveld43 assumes that besides a
primary physiological pathway, comprising neurosensory
signals, a secondary pathway of learning processes and
emotions can lead to the sensation of dyspnea. Under
certain circumstances, e.g., reduced sensitivity to physio-
logical signals, the latter pathway might become the main
source of subjective and perhaps inadequate perception of
dyspnea, irrespective of the actual state of the respiratory
system. For definite conclusions to be drawn on this
assumption and laboratory findings further studies are
required, particularly in naturalistic settings.
Attention and dyspnea
Many results in the pain literature have shown, focusing
attention away from a painful stimulus can reduce the level
of perceived pain.44 A prominent explanation for thisobservation is Pennebaker’s theory of competition of cues.45
It assumes that internal and external stimuli compete for
the limited attentional resources in an individual. If
attention is focused on external stimuli, less capacity is
available for the processing of internal stimuli such as pain.
In the field of dyspnea research there exist only a few
studies that provide conflicting evidence on the effects of
attention. In a study by Thornby et al.46 COPD patients
underwent physical exercise tests. Compared to control
conditions, distraction by music led to an increase of
duration and intensity of exercise by 22% and 40%,
respectively, in addition to which fewer symptoms were
reported. Similar results were demonstrated by Bauldoff
et al.47 in COPD patients who were distracted by music
during treadmill exercise in their home environment when
compared to patients who were not distracted. Two further
studies, using similar designs, could not replicate the
beneficial effects of attentional distraction.48,49 Never-
theless it has been shown that focusing attention away
from respiratory sensations, results in a parallel reduction of
cortical activity. Harver et al.50 demonstrated higher
latencies and smaller amplitudes of RREPs when participants
were instructed to ignore a respiratory occlusion as opposed
to when they focused their attention on it.
Psychological and behavioural interventions in
the treatment of dyspnea
Behavioural and psychological interventions are increasingly
recognised as effective treatment options in addition to
purely medical interventions. Patient education methods,
focusing on behavioural changes51,52 are considered as
essential module and the key to successful and long-lasting
treatment outcome in treatment programs for obstructive
pulmonary diseases.53 It should, however, be pointed out
that due to the somatic origin of asthma and COPD no
behavioural interventions should be applied without prior
treatment by a pulmonary physician or the collaboration of
such a physician.54
Interoceptive interventions
An important aim of patient training is the development of
an increased sensitivity to the perception of respiratory
symptoms.4,53 One strategy in this respect is to learn the
individually relevant alarm signals of a beginning broncho-
constriction, e.g., wheezing, coughing or chest tightness.
Specific questionnaires can be used for the assessment of
these symptoms and in the further course of treatment
control. For example, the asthma symptom checklist55
assesses on five dimensions physical (obstruction, hyperven-
tilation) and psychological symptoms (anxiety, irritability
and fatigue). In particular, a clear differentiation between
respiratory and psychological symptoms might lead to a
more realistic perception of the lung function.
A common training method is the estimation of lung
function in terms of peak expiratory flow (PEF) followed by
the actual measurement of PEF and last a comparison of
both values. In a study by Vogt and Schandry9 patients with
asthma rated their PEF daily, followed by an objective
feedback provided by measuring PEF. After 30 days the
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A development of this method was a computer-assisted
patient training in which patients with asthma daily rated
their PEF and ten symptoms of asthma followed by visual
feedback of the measured PEF.56 Compared to the control
group without daily PEF and symptom ratings, the PEF group
showed an 18% increase in accuracy of perceived lung
function after the training. This was associated with a
significant decrease of perceived asthma symptoms and
increased asthma-related quality of life. This method, when
carefully adapted, can also be successfully used with
preschool children.57
In a more complex training method, using biofeedback
procedures, patients have to differentiate between differ-
ent levels of dyspneic stimuli (e.g., resistive loads of varying
magnitude) followed by immediate feedback. Although the
compatibility of this method for bronchoconstrictions in
everyday life is still under debate, positive effects have
been reported. In a study by Harver et al.58 individuals with
asthma who received feedback on the accuracy of their
ratings showed an increased sensitivity to the perception of
the loads compared to individuals who did not receive such
feedback. Recently, these results were replicated in
children with asthma.59 In contrast, an elaborated biofeed-
back perception training by Dahme et al.60 provided less
optimistic results. After a training aimed at lowering
respiratory resistance through continuous feedback, per-
ceptual accuracy of estimating resistive loads had only
marginally increased compared to the pre-training period.
Moreover, the control group showed similar changes without
having received any training.
Despite the increasing use of trainings that enhance the
sensitivity towards dyspneic symptom perception, long-term
follow-up studies remain absent. The further improvement
of the sensitivity to symptom perception, however, con-
tinues to be an important aim for future developments of
patient training, particularly in the field of behavioural
medicine.53 In this respect, Leopold and Schandry56 empha-
size the importance of individualised components within
group trainings, which are focused on specific character-
istics of each single patient.
A new and barley examined option of self-management
programs uses the internet. Nguyen et al.61 previously
demonstrated promising results in a pilot study examining
the effects of an Internet-based dyspnea self-management
program. Sixteen patients with COPD took part in the
program that offered several modules of patient education,
self-monitoring, training instructions and patient encour-
agement via the Internet. After the 3-month program
patients showed decreased dyspnea during activities of
daily life and increased self-efficacy in managing their
symptoms.Physical interventions
The positive effects of physical exercise on health status and
quality of life are well established. These are also evident in
obstructive pulmonary diseases and associated with in-
creased thresholds of dyspnea. Therefore, motivating
patients to regularly perform physical exercise is a
prominent behavioural intervention in many patient train-ings for obstructive pulmonary diseases.62 Particularly the
strengthening of the inspiratory muscles has been shown
to be highly effective in reducing the intensity of perceived
dyspnea, thus leading to a more realistic perception of
lung function. These non-pharmacological interventions
have a strong theoretical rational and improve exercise
tolerance as well as quality of life.63 For example, Weiner
et al.64,65 demonstrated significant increases of inspiratory
muscle strength and clearly reduced dyspnea in patients
with asthma and COPD following a 3-month inspiratory
muscle training. In asthmatic patients this effect was
associated with a considerable decrease of bronchodilator
consumption by 38.5%. The achieved improvements in
patients with COPD, however, were only maintained over
the course of 1 year if the training was continued. The
control group that discontinued the incremental muscle
training after 3 months showed a progressive decline in their
performance.
Furthermore, several breathing methods such as abdom-
inal breathing, pursed lip breathing and nasal breathing
have been reported to be effective in reducing the level of
perceived dyspnea. A systematic review by Ritz and Roth,66
however, showed that the physiological rationale of these
techniques is often neither clear nor examined and that
clinical evidence for the effectiveness of specific breathing
methods is mostly not available. Since some techniques
might even entail the risk of aversive side effects, future
studies with adequate methodologies are needed to explore
the real potential of these interventions.Attentional interventions
The aforementioned methods of patient training aim to
improve the sensitivity to the perception of breathlessness
and hence focus the attention of patients on the respiratory
system. The contrary strategy of focusing the attention
away from breathing can equally be effective. As has been
shown by Thornby et al.46 and Bauldoff et al.,47 such
distraction can lead to reduced feelings of dyspnea in
patients with COPD. This intervention could be particularly
useful in controlled physical exercise regimes in pulmonary
rehabilitation, which aim to improve physical fitness. In the
common case of patients with a long history of exercise
avoidance these regimes are often aversively perceived in
the beginning, because low fitness levels often result in
dyspnea during physical exercise. Non-pharmacological
distraction strategies, e.g., with music, visual stimuli or
imagination, might effectively improve patient motivation
and lead to prolonged and more intensive exercise while less
aversive breathlessness is perceived. Moreover, patients for
whom even intensive medical treatment does not provide
adequate alleviation of their symptoms, might perceive
their symptoms to be less aversive when using distraction
techniques. Successful interventions might also increase the
self-efficacy of patients, which in turn might motivate the
seeking of further treatment interventions.62,67 Since only a
few studies have systematically examined this method to
date, attentional interventions should not be applied in
patients with poorly controlled diseases and never replace
medical interventions.
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Based on current findings, the generalised application of
psychotherapy to the treatment of dyspnea is unsup-
ported.54 On the other hand it has been mentioned earlier
in this report that obstructive pulmonary diseases show a
high comorbidity of depressive and anxiety disorders. In the
case of such psychological comorbidities psychotherapy in
addition to medical treatment is clearly called for and
might, in turn, help to improve the sensitivity to the
perception of dyspnea. A recent review by Brenes68
demonstrated that cognitive behavioural treatment pro-
grams, but also psychopharmacological treatments and
multi-component pulmonary rehabilitation programs, were
able to reduce anxiety in patients with COPD. In this regard,
Kunik et al.69 demonstrated in patients with COPD that as
little as 2 h of a group therapy containing elements of
cognitive behavioural therapy can lead to a reduction of
symptoms of depression and anxiety compared to a control
group who only received patient education. The group
therapy included one part of education on depression,
anxiety and associated effects on chronic medical illness.
A second part included instructions on coping skills to aid in
the control of these symptoms, e.g. relaxation techniques,
thought stopping, self-instructions and exposures to anxiety-
producing situations which should be practised at home.
Other treatment programs using comparable cognitive
behavioural elements combined with patient education
showed similar improvements in negative affectivity, anxi-
ety, respiratory symptoms and quality of life in patients with
asthma.51,70 That these improvements can also influence the
perception of dyspnea was shown for patients with COPD in a
small study by Renfroe.71 However, further studies are
clearly required to understand how psychotherapeutic
interventions might help to improve the perception of
breathlessness.
Of further importance to an improved perception of
dyspneic sensations is a clear differentiation between the
physiologically concomitant real symptoms of a broncho-
constriction and anxious states such as tachycardia, hyper-
ventilation and dizziness. Such a differentiation can prevent
inadequate treatment caused by the over-perception of
dyspneic symptoms and interrupt the process of interactive
exacerbation.17 Concerning this, Feldman et al.72 have
demonstrated that patients with asthma and comorbid
panic disorder showed poorer treatment outcome than a
control group with no symptoms of panic. In addition, a
behavioural, medically oriented psychotherapy or respec-
tive patient training51,67 can lead to improved self-efficacy,
treatment motivation and patient compliance, which in turn
might directly or indirectly result in an improved perception
of dyspnea and improved clinical outcome.62
Despite these promising preliminary results, Steinkamp
et al.73 recently concluded that to date no consensus exists
on how to treat psychological disorders in COPD. The same
holds for psychotherapeutic interventions in asthma. The
available evidence is still limited and studies are often not
comparable, of small sample size or of questionable
methodological quality.74 This is mirrored by missing
statements concerning this issue in international guidelines
on asthma and COPD.4,18 Therefore, more studies of
appropriate methodological quality are clearly needed todraw firm conclusions. In addition, many patients with
obstructive pulmonary diseases are not recognised as having
a comorbid psychological disorder and thus do not receive
any psychotherapeutic treatment. Kunik et al.38 reported in
a large study that merely 31% of patients with COPD who had
a well-diagnosed comorbid anxiety or depression were
receiving psychological treatment. One reason might be
the limited psychodiagnostic experience of some physicians,
who are in many circumstances the primary, and often the
only contact persons for these patients in the health care
system. Moreover, economic reasons might prevent a more
intensive dialogue between the physician and the patient
about the psychological state of the patient. In this respect,
time and cost-effective screening instruments for the
assessment of psychopathological factors can be a first step
in detecting potential comorbidities. The Hospital Anxiety
and Depression Scale (HADS)75 is, among others, an
adequate example of a short self-administered question-
naire. It comprises 14 questions, seven of which are aimed
at assessing anxiety and seven at detecting depression.
Positive findings in a screening should be followed up by
sound diagnostic and interventional steps, preferentially by
an experienced psychotherapist. An increased interdisci-
plinary collaboration based on principles of behavioural
medicine between medical and psychological professionals
would therefore be most effective to the treatment of
dyspnea in obstructive pulmonary diseases, particularly for
out-patients.52Conclusion
It has been shown that inaccurate perception of dyspnea in
obstructive pulmonary diseases is associated with poorer
treatment outcome, inadequate health care use and
reduced quality of life. First neuropsychological findings
describe distinct brain areas involved in the processing of
this sensation and suggest that possible deficits in the higher
processing might contribute to the inaccurate perception of
dyspnea. Overall, available evidence indicates that differ-
ent psychological factors can have an important influence on
this interoceptive process and the further course of disease.
The studies discussed here suggest that the perception of
breathlessness consists of distinct dimensions and is influ-
enced by negative emotionality, attention and learning
processes. Further, psychological aspects are relevant to a
variety of treatments of dyspnea and obstructive pulmonary
diseases. These contain behaviourally oriented training
programs, interoceptive training, physical exercise regimes
and psychotherapeutic interventions. Despite the findings
from the reviewed studies and the first promising results of
intervention techniques, many questions are still not
answered. Future studies are clearly needed to substantiate
these first findings and to provide more detailed insights into
the psychological aspects surrounding the perception of
dyspnea in obstructive pulmonary diseases.Acknowledgements
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